Mark J Gergen Insider Trading $PSTX Poseida Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mark J Gergen.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mark J Gergen. Mark J Gergen is Sr VP Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and Sr VP, Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP, Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP, Chief Operating Officer in HALOZYME THERAPEUTICS INC ($GYHT) and Executive VP, COO in Mirati Therapeutics, Inc. ($MYG) and President and CBO in Poseida Therapeutics, Inc. ($PSTX).

Mark J Gergen in Poseida Therapeutics, Inc.

Trading Symbol: PSTX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark J Gergen: President and CBO
Holdings: 0 shares
Latest Transaction: Feb 05 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Mark J Gergen in Poseida Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AMLN, GYHT, MYG, PSTX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
Feb 05 2021	PSTX	Poseida Therapeuti ...	Gergen Mark J	President and CBO	Option Exercise	A	9.15	342,000	3,129,300	342,000
Feb 05 2021	PSTX	Poseida Therapeuti ...	Gergen Mark J	President and CBO	Option Exercise	A	9.15	342,000	3,129,300	342,000
Jul 13 2020	PSTX	Poseida Therapeuti ...	Gergen Mark J	President and CBO	Option Exercise	A	16.00	75,000	1,200,000	75,000

Page: 1